C20orf11 |
C20orf11: Protein C20orf11 |
FLJ13910 |
IPI00009707 |
3.34 |
Evidence |
O
|
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
GNB2 |
GNB2: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 |
3.325 |
Evidence |
|
RRAS2 |
RRAS2, TC21: Ras-related protein R-Ras2 precursor |
SMURF2 |
SMURF2: E3 ubiquitin-protein ligase SMURF2 |
3.317 |
Evidence |
O
|
U2AF2 |
U2AF2, U2AF65: Splicing factor U2AF 65 kDa subunit |
SFRS1 |
SFRS1, ASF, OK/SW-cl.3, SF2, SF2P33: Splicing factor, arginine/serine-rich 1 |
3.317 |
Evidence |
|
DMD |
DMD: Dystrophin |
SNTG1 |
SNTG1: Gamma-1-syntrophin |
3.317 |
Evidence |
|
PARD3 |
IPI00154915 |
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
3.317 |
Evidence |
|
SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
3.317 |
Evidence |
|
CAST1 |
ERC2, KIAA0378: ERC protein 2 |
PPFIA1 |
PPFIA1, LIP1: Liprin-alpha-1 |
3.317 |
Evidence |
|
PPFIA1 |
PPFIA1, LIP1: Liprin-alpha-1 |
PPFIA2 |
PPFIA2: Liprin-alpha-2 |
3.317 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
3.285 |
Evidence |
O
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PEBP1 |
PEBP1, PBP, PEBP: Phosphatidylethanolamine-binding protein 1 |
3.262 |
Evidence |
O
|
WDR12 |
WDR12: WD repeat-containing protein 12 |
DDX54 |
DDX54: ATP-dependent RNA helicase DDX54 |
3.222 |
Evidence |
O
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
3.202 |
Evidence |
|
MEF2C |
MEF2C: Myocyte-specific enhancer factor 2C |
MEF2D |
MEF2D: Myocyte-specific enhancer factor 2D |
3.202 |
Evidence |
|
SP1 |
SP1, TSFP1: Transcription factor Sp1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
3.202 |
Evidence |
|
PLD2 |
PLD2: Phospholipase D2 |
GAPD |
GAPDH, GAPD, CDABP0047, OK/SW-cl.12: Glyceraldehyde-3-phosphate dehydrogenase |
3.202 |
Evidence |
|
TTC4 |
TTC4, My044: Tetratricopeptide repeat protein 4 |
HSP90AA1 |
Hsp89-alpha-delta-N |
3.2 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
CNOT7 |
CNOT7, CAF1: CCR4-NOT transcription complex subunit 7 |
3.2 |
Evidence |
O
|
CDK4 |
CDK4: Cell division protein kinase 4 |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
3.195 |
Evidence |
O
|
MARK4 |
IPI00297959 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
3.187 |
Evidence |
|
NMI |
NMI: N-myc-interactor |
STAT3 |
|
3.187 |
Evidence |
|
RHOQ |
RHOQ, ARHQ, RASL7A, TC10: Rho-related GTP-binding protein RhoQ precursor |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
3.187 |
Evidence |
|
GSN |
GSN: Gelsolin precursor |
ACTA1 |
ACTA1, ACTA: Actin, alpha skeletal muscle |
3.187 |
Evidence |
O
|
CCNE2 |
CCNE2: G1/S-specific cyclin-E2 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
3.187 |
Evidence |
|
SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
SMN2 |
SMN1, SMN, SMN2, SMNC, SMNT: Survival motor neuron protein |
3.187 |
Evidence |
|